Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Result of AGM

1st Oct 2026 15:57

RNS Number : 2874X
MyCelx Technologies Corporation
01 October 2026
 

1 October 2026

 

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX or MYXR)

 

Result of Adjourned Annual Meeting

 

The Company is pleased to announce that, at its adjourned Annual Meeting held on 1 October 2026 at 1650 International Court, Suite 100, Norcross, Georgia 30093, U.S.A., the resolutions set out in the Notice of Annual Meeting were duly passed on a Poll.

 

Full details of the resolutions passed are set out in the Notice of Meeting which is available on the Company's website www.mycelx.com.

 

Resolutions

For / Discretion

Against

Total

Vote withheld*

Number

%

Number

%

1A To elect Tom Lamb as a Director

 

12,290,446

 

100.00

 

-

 

-

12,290,446

 

-

1B To elect Connie Mixon as a Director

12,290,446

 

100.00

 

-

 

 

 

-

12,290,446

 

-

1C To elect Haluk (Hal) Alper as a Director

 

12,290,446

 

100.00

-

-

12,290,446

 

-

1D To elect Torben Wetche as a Director

 

12,290,446

 

100.00

-

-

12,290,446

 

 

-

 

2. Ratification of appointment of BDO USA P.C.as independent registered public accounting firm

 

12,290,446

 

100.00

-

-

12,290,446

 

-

3. the approval by way of an advisory vote of the Directors' Remuneration Report for the year ended 31 December 2025

 

10,298,240

100.00

-

-

10,298,240

-

 

*'Vote withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution.

 

For further information please contact:

 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

 

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Giles Balleny / Callum Davidson / Elysia Bough (Corporate Finance)

Harriet Ward (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)

 

 

 

 

Tel: +1 888 306 6843

 

 

Tel: +44 20 7220 0500

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUAVSRNVURRAA

Related Shares:

Mycelx Di
FTSE 100 Latest
Value10,461.95
Change33.68